Clinical Trials Logo
  1. Home
  2. Female Pattern Baldness
  3. NCT05409755
  4. Details
NCT05409755 Clinical Trial

Radiofrequency in Female Pattern Hair Loss

Female Pattern Baldness Clinical Trial

Official title:
Efficacy of Fractional Needling Radiofrequency in Female Pattern Hair Loss, a Randomized Controlled Trial.

Clinical Trial Details — Status: Not yet recruiting

Administrative data
NCT number NCT05409755
Other study ID # Female pattern hair loss
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date June 25, 2022
Est. completion date September 15, 2022

Study information
Verified date June 2022
Source Cairo University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Pattern hair loss, also called androgenetic alopecia (AGA) is considered the most common cause of hair loss in both males and females affecting approximately 85% of males and 50% of females over 50 years of age.

Description:

RF (Radiofrequency) based devices have also been shown to be successful in promoting hair growth, thought to occur through the induction of growth factors in the papillary dermis. Studying the effect of fractional needling radiofrequency in the treatment of female pattern hair loss will pave the way for more treatment options for this common disease.

Recruitment information / eligibility
Status Not yet recruiting
Enrollment 30
Est. completion date September 15, 2022
Est. primary completion date September 15, 2022
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 60 Years
Eligibility Inclusion Criteria: - Patients with female pattern hair loss Exclusion Criteria: - - Pregnancy and lactation. - Bleeding tendency. - Cases who received treatment (systemic or topical) in the last 3 months before treatment. - Scarring alopecia. - Other associated causes of alopecia

Study Design

Related Conditions & MeSH terms

Intervention

Other:
• Vivacy
Vivacy and minoxidil

Locations
Country Name City State
n/a

Sponsors (1)
Lead Sponsor Collaborator
Cairo University

Outcome
Type Measure Description Time frame Safety issue
Primary Clinical examination by Sinclair scale Clinical 3 months
See also
  Status Clinical Trial Phase
Completed NCT00981461 - Treatment of Androgenetic Alopecia in Females, 9 Beam N/A
Completed NCT01451021 - A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss Phase 2
Completed NCT01451138 - A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0004541) Phase 2
Completed NCT03351322 - ENERGI-F701 for Female Hair Loss Treatment Phase 2
Completed NCT01451177 - A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0004669) Phase 2
Completed NCT01451125 - A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0004512) Phase 2
Recruiting NCT06333600 - Efficacy and Safety of Topical Vitamin D Analogue in Treatment of Female Pattern Hair Loss Phase 1/Phase 2
Not yet recruiting NCT05888922 - Evaluation of Efficacy and Safety of Oral Minoxidil 1 mg in Female Androgenetic Alopecia Phase 3
Completed NCT01669746 - A Study to Evaluate and Compare Injections of Autologous Mixed Population of Dermal Cells Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0006931) Phase 2
Completed NCT01451099 - A Study to Evaluate and Compare Injections of Autologous Dermal Cells Into the Balding Scalp of Subjects With Hair Loss Phase 2
Withdrawn NCT04379583 - HairDx Analytical Validation Study
Completed NCT01451190 - A Study to Evaluate and Compare Injections of Autologous Mixed Population of Dermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0005995) Phase 2
Completed NCT01451047 - A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0002012) Phase 2
Not yet recruiting NCT05824065 - Efficacy and Safety of OMA102 in the Treatment of Female Pattern Hair Loss Phase 3
Not yet recruiting NCT02316418 - Hairstetics™ Anchoring System in Female Pattern Hair Loss (HAS-FPHL) N/A
Completed NCT01016964 - Treatment of Androgenetic Alopecia in Females, 12 Beam N/A
Completed NCT01451073 - A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0002013) Phase 2
Completed NCT01451151 - A Study to Evaluate and Compare Injections of Autologous Mixed Population of Dermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0004542) Phase 2
Completed NCT04898166 - Association of Androgenetic Alopecia and Severity of Coronavirus Disease 2019 (COVID-19).
Completed NCT01451112 - A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0002899) Phase 2